Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen [Phase 1]
Phase 1 study of a mixed bacteria vaccine (MBV) targeting NY-ESO-1 tissue expression in various tumors; completed with posted results.
-
FDA approval · 2017-01-06FDA Approved: FLUOROURACIL — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Fluorouracil from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating EpCAM-targeted CAR T cells across multiple cancers, including colon, esophageal, pancreatic, prost…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent. [Phase 2]
A Phase 2 clinical trial evaluating covered or partially covered stents for malignant esophageal and gastroesophageal junction strictures ha…
-
FDA approval · 2016-12-27FDA Approved: FLUOROURACIL — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Fluorouracil (5-fluorouracil) from Eugia US LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-12-15Clinical Trial Update: Study of Inspiratory Muscle Training for Patients Undergoing Esophageal Surgery [NA]
The clinical trial evaluating inspiratory muscle training for patients undergoing esophageal surgery has been withdrawn.
-
FDA approval · 2016-12-14FDA Approved: FLUOROURACIL — Supplemental Application (Eugia US LLC)
The FDA has approved a supplemental application for Fluorouracil from Eugia US LLC, formalizing an update to the product under the ANDA path…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Acceptability of Less Harmful Alternatives to Cigarettes [NA]
This completed clinical trial posted results in 2016 evaluating the acceptability of less harmful alternatives to cigarettes across multiple…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
A Phase 2 study evaluating the combination of bortezomib, paclitaxel, and carboplatin in unresectable, metastatic esophageal or gastroesopha…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction [Phase 2]
A Phase 2 study evaluating docetaxel plus capecitabine for metastatic stomach or gastroesophageal junction cancer has completed. The trial w…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer [Phase 2]
A Phase 2 trial evaluating gefitinib for locally advanced esophageal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer [Phase 2]
Phase 2 clinical trial of oxaliplatin and capecitabine in advanced esophageal and gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
This is a Phase 2 trial evaluating a trimodality approach—radiation therapy followed by paclitaxel, carboplatin, and fluorouracil, and then …
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach [Phase 1, Phase 2]
Phase I/II trial evaluating tivantinib with FOLFOX for advanced solid tumors including metastatic adenocarcinoma of the distal esophagus, ga…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Phase II Study of Irinotecan and Panitumumab [Phase 2]
Phase II study evaluating the combination of irinotecan and panitumumab in esophageal cancer has completed and posted its results.
-
CLINICAL_TRIALS research · 2016-11-10Clinical Trial Update: Different Anesthetic Managements of Esophageal Resection and Reconstruction [NA]
A clinical trial from National Taiwan University Hospital examining different anesthetic management strategies for esophageal resection and …
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
This entry notes the completion of a clinical trial investigating physical and psychosocial rehabilitation needs in patients after diagnosis…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: FDG-PET-CT and Biomarkers in Esophageal Cancer [NA]
This clinical trial update notes that the study evaluating FDG-PET-CT imaging and biomarkers in esophageal cancer has completed. The sponsor…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors [NA]
A clinical trial from University Hospital Tuebingen compares short-term starvation versus a normal diet before chemotherapy in solid tumors;…
-
CLINICAL_TRIALS research · 2016-10-28Clinical Trial Update: Iron Replacement in Oesophagogastric Neoplasia [Phase 4]
This document provides an update on a Phase 4 trial of iron replacement therapy for anemia in patients with esophageal or gastric cancer.
-
CLINICAL_TRIALS research · 2016-10-21Clinical Trial Update: Cologne Esophageal Response Prediction Study (CERP-Study) [NA]
A completed clinical trial evaluating predictors of treatment response in esophageal cancer (CERP-Study).
-
CLINICAL_TRIALS trial_result · 2016-10-13Clinical Trial Update: Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating celecoxib for cancer prevention in patients with Barrett's e…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating an NY-ESO-1 vaccine therapy with or without sirolimus in patients whose tumors express NY-ESO-1.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Dexmedetomidine and Hypoxic Pulmonary Vasoconstriction in Thoracic Surgical Procedures and One-Lung Ventilation
Clinical trial update on the use of dexmedetomidine to study its effects on hypoxic pulmonary vasoconstriction during thoracic surgery and o…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Deep Neuromuscular Relaxation in Patients for Thoraco-laparoscopic Esophagectomy [Phase 4]
Phase 4 clinical trial evaluating deep neuromuscular relaxation during thoraco-laparoscopic esophagectomy has completed.